Metformin is one of the most widely prescribed medicines in the UK and it reduces vitamin B12 absorption. The association is well established, appears in prescribing guidance, and matters particularly because the symptoms of B12 deficiency closely resemble the diabetic nerve damage that metformin is prescribed to help prevent.
How does metformin interfere with B12?
The mechanism is not fully settled, and the leading explanation involves calcium. Absorption of the B12 and intrinsic factor complex at receptors in the terminal ileum is calcium dependent, and metformin appears to interfere with calcium availability at the cell membrane.
Supporting this, some studies have found that calcium supplementation reverses the absorption defect, though this has not translated into a routine clinical recommendation.
Other proposed contributions include changes to gut bacteria and altered bile acid handling. The effect on absorption is well documented regardless of which explanation eventually proves correct.
How common is it?
Studies have reported low B12 in a meaningful minority of long term metformin users, with estimates varying widely depending on the threshold used and the population studied. Figures in the range of 10 to 30 per cent appear frequently.
The risk increases with dose and with duration. People on higher doses for many years are most affected, and the effect is generally not apparent in the first year or two.
Large trials with long follow up have confirmed a progressive decline in B12 levels over years of treatment rather than a one off drop.
Why does the overlap with neuropathy matter?
This is the clinically important part. Diabetic peripheral neuropathy causes numbness, tingling and burning in the feet and hands. B12 deficiency causes almost exactly the same symptoms.
Someone with type 2 diabetes on long term metformin who develops tingling feet may be assumed to have diabetic neuropathy when the cause is a treatable vitamin deficiency. That assumption is easy to make and delays correction.
Diabetic neuropathy is largely irreversible. B12 deficiency neuropathy often reverses if treated early. Distinguishing them is worth doing.
What does guidance recommend?
Prescribing guidance advises considering B12 monitoring in people on long term metformin, particularly those with symptoms suggesting deficiency or with risk factors such as anaemia or peripheral neuropathy.
The frequency of monitoring is not tightly specified and practice varies. Annual or periodic checking is a common approach for long term users.
It is reasonable to ask your GP about B12 testing if you have been on metformin for several years, especially if you have any numbness or tingling.
Should you stop metformin?
No. Metformin is an effective and well established treatment with substantial benefits, and B12 deficiency is straightforward to correct without stopping it.
Treatment is usually oral B12 supplementation, and injections may be used where deficiency is severe or neurological symptoms are present. The medicine continues alongside.
Never stop or change prescribed medication on the basis of an article. Raise it with your GP or diabetes team.
Which other medicines affect B12?
- Proton pump inhibitors such as omeprazole, which reduce the stomach acid needed to release B12 from food
- H2 blockers such as ranitidine and famotidine, by a similar mechanism
- Colchicine, which can affect absorption in the ileum
- Nitrous oxide, which inactivates B12 directly and can cause rapid severe deficiency
Acid reducing medicines are particularly relevant because they are widely prescribed for years at a time and are frequently taken by the same people who take metformin, compounding the effect on absorption without anyone noticing the combination.
What should you do?
If you take metformin long term, mention B12 at your next diabetes review and ask whether testing is appropriate. Report any numbness, tingling, unsteadiness or memory change promptly rather than assuming it is expected.
Do not start high dose B12 before testing if you can avoid it, since supplementation normalises the blood result and makes the underlying problem harder to identify. This article is general information and not medical advice, and prescribed medicines should only be changed on medical advice.